Distinct clinical, neuroimaging and genetic profiles of late-onset cobalamin C defects (cb1C): a report of 16 Chinese cases

[1]  M. Irving,et al.  Best practice guidelines for management of spinal disorders in skeletal dysplasia , 2020, Orphanet Journal of Rare Diseases.

[2]  M. Baumgartner,et al.  Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: data from the E-HOD registry , 2018, Journal of Inherited Metabolic Disease.

[3]  W. Craigen,et al.  Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening. , 2017, Molecular genetics and metabolism.

[4]  M. Baumgartner,et al.  Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency , 2016, Journal of Inherited Metabolic Disease.

[5]  G. Diaz,et al.  Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance. , 2015, Molecular genetics and metabolism.

[6]  R. Banerjee,et al.  Pathogenic Mutations Differentially Affect the Catalytic Activities of the Human B12-processing Chaperone CblC and Increase Futile Redox Cycling* , 2015, The Journal of Biological Chemistry.

[7]  J. Lupski,et al.  Whole Exome Sequencing Identifies an Adult-Onset Case of Methylmalonic Aciduria and Homocystinuria Type C (cblC) with Non-Syndromic Bull’s Eye Maculopathy , 2015, Ophthalmic genetics.

[8]  M. Baumgartner,et al.  Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy , 2014, Orphanet Journal of Rare Diseases.

[9]  Eda Özaydın,et al.  Reversible pulmonary arterial hypertension in cobalamin-dependent cobalamin C disease due to a novel mutation in the MMACHC gene , 2014, European Journal of Pediatrics.

[10]  M. Baumgartner,et al.  Clinical presentation and outcome in a series of 88 patients with the cblC defect , 2014, Journal of Inherited Metabolic Disease.

[11]  T. Naidich,et al.  Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. , 2013, Molecular genetics and metabolism.

[12]  J. Jia,et al.  A clinical and gene analysis of late-onset combined methylmalonic aciduria and homocystinuria, cblC type, in China , 2012, Journal of the Neurological Sciences.

[13]  R. Chandler,et al.  Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management , 2012, Journal of Inherited Metabolic Disease.

[14]  C. Venditti,et al.  Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes , 2012, Journal of Inherited Metabolic Disease.

[15]  Xuefan Gu,et al.  Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China , 2010, Journal of Inherited Metabolic Disease.

[16]  E. Richard,et al.  Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC) , 2009, Human mutation.

[17]  M. Baumgartner,et al.  Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype–phenotype correlations , 2009, Human mutation.

[18]  A. Radmanesh,et al.  Methylmalonic acidemia: brain imaging findings in 52 children and a review of the literature , 2008, Pediatric Radiology.

[19]  G. Uziel,et al.  Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type. , 2008, Molecular genetics and metabolism.

[20]  F. Sedel,et al.  Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: A diagnostic approach , 2007, Journal of Inherited Metabolic Disease.

[21]  S. Blaser,et al.  Late‐onset cobalamin‐C disorder: A challenging diagnosis , 2007, American journal of medical genetics. Part A.

[22]  C. Morel,et al.  Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. , 2006, Molecular genetics and metabolism.

[23]  M. Seashore,et al.  Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC) , 1997, Journal of Inherited Metabolic Disease.

[24]  E. Shoubridge,et al.  Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type , 2006, Nature Genetics.